| |
| |
|
| Insider
Information: |
Crooke Stanley T |
| Relationship: |
Director, 10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,021 |
|
|
Indirect Shares
|
7,547,002 |
|
|
| Direct
Value |
$75,929 |
|
|
|
Indirect Value
|
$34,834,505 |
|
|
| Total
Shares |
7,549,023 |
|
|
| Total
Value |
$34,910,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Exec Chairman of the B... |
2021-01-26 |
2,021 |
2021-01-26 |
497,502 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
463 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 19 of 19
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2020-11-24 |
4 |
OE |
$39.87 |
$103,263 |
D/D |
2,590 |
4,611 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2020-11-25 |
4 |
OE |
$39.87 |
$517,911 |
D/D |
12,990 |
15,011 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2020-11-25 |
4 |
AS |
$50.05 |
$650,150 |
D/D |
(12,990) |
2,021 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2020-12-07 |
4 |
AS |
$51.50 |
$568,351 |
I/I |
(11,000) |
639,391 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2020-12-15 |
4 |
AS |
$49.78 |
$1,941,225 |
I/I |
(39,000) |
600,391 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2020-12-17 |
4 |
AS |
$50.50 |
$71,054 |
I/I |
(1,407) |
174 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2021-01-15 |
4 |
D |
$61.28 |
$87,876 |
I/I |
(1,434) |
3,111 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,371 |
4,545 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2021-01-15 |
4 |
D |
$61.28 |
$1,159,663 |
D/D |
(18,924) |
30,354 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,257 |
49,278 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2021-01-21 |
4 |
AS |
$60.53 |
$2,142,117 |
I/I |
(35,000) |
534,391 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2021-01-22 |
4 |
AS |
$61.68 |
$2,467,000 |
I/I |
(40,000) |
494,391 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2021-01-26 |
4 |
AS |
$63.74 |
$1,805,812 |
D/D |
(28,333) |
2,021 |
0 |
% |
|
463 Records found
|
|
Page 19 of 19 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
